New research demonstrated that neutrophils and CSF1 signaling contribute to the expansion of alveolar macrophages derived ...

Pleuroparenchymal fibroelastosis shows a distinctive phenotype with frequent pleural complications, low body mass index, ...

Researchers outlined a potential explanation for divergent responses to tirzepatide observed in a mitochondrial myopathy case and a BMD case.

Rilzabrutinib demonstrated durable efficacy and a favorable safety profile for the treatment of warm AIHA in the phase 2b LUMINA 2 trial.

Pediatric patients with mtARS disorders who received amino acid supplementation showed improvement, justifying larger studies ...

Across follow-up, tirzepatide exposure was associated with fewer major adverse liver outcomes and hospitalizations in ...

Researchers linked a family’s novel LPL variant to impaired LPL release, although they did not diagnose any family members ...

A network meta-analysis found that rifampin ranked highest for change in pruritus score, followed by linerixibat, in patients ...

Amgen Canada announced that inebilizumab is now available in the country as an add-on to standard therapy for adults with ...

Seladelpar achieved the highest comparative ranking for biochemical response and ALP normalization in patients with PBC.

Patients with concurrent PBC and osteoporosis do not have an increased risk of major bone fracture vs patients with ...

In a proof-of-concept study, deep red light therapy was well tolerated but did not improve ptosis in teenagers with ...